170 related articles for article (PubMed ID: 31432147)
1. An 8‑gene signature predicts the prognosis of cervical cancer following radiotherapy.
Xie F; Dong D; Du N; Guo L; Ni W; Yuan H; Zhang N; Jie J; Liu G; Tai G
Mol Med Rep; 2019 Oct; 20(4):2990-3002. PubMed ID: 31432147
[TBL] [Abstract][Full Text] [Related]
2. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
3. Elastic Net-Based Identification of a Multigene Combination Predicting the Survival of Patients with Cervical Cancer.
Wang H; Li SW; Li W; Cai HB
Med Sci Monit; 2019 Dec; 25():10105-10113. PubMed ID: 31884508
[TBL] [Abstract][Full Text] [Related]
4. A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
Liu CP; Zhang JH; Zheng SC; Liu J; Guo JC
Oncol Rep; 2018 Nov; 40(5):2826-2835. PubMed ID: 30226624
[TBL] [Abstract][Full Text] [Related]
5. An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
Ma JH; Huang Y; Liu LY; Feng Z
J Int Med Res; 2021 May; 49(5):3000605211018443. PubMed ID: 34034542
[TBL] [Abstract][Full Text] [Related]
6. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of prognosis prediction models based on pathway‑level, gene‑level and clinical information for glioblastoma.
Liang R; Wang M; Zheng G; Zhu H; Zhi Y; Sun Z
Int J Mol Med; 2018 Oct; 42(4):1837-1846. PubMed ID: 30015853
[TBL] [Abstract][Full Text] [Related]
8. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
[TBL] [Abstract][Full Text] [Related]
9. Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
Yang J; Bo L; Han T; Ding D; Nie M; Yin K
Mol Med Rep; 2018 May; 17(5):6345-6356. PubMed ID: 29532879
[TBL] [Abstract][Full Text] [Related]
10. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Yan J; Zhou C; Guo K; Li Q; Wang Z
J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981
[TBL] [Abstract][Full Text] [Related]
11. Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma.
Huang L; Zheng M; Zhou QM; Zhang MY; Yu YH; Yun JP; Wang HY
Med Oncol; 2012 Dec; 29(4):2911-8. PubMed ID: 22274917
[TBL] [Abstract][Full Text] [Related]
12. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
13. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
14. Analysis of CASP12 diagnostic and prognostic values in cervical cancer based on TCGA database.
Feng G; Beilei Z; Caizhi C; Wen Z
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31804677
[TBL] [Abstract][Full Text] [Related]
15. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
16. Integrated gene expression profile predicts prognosis of breast cancer patients.
Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
[TBL] [Abstract][Full Text] [Related]
17. Gene expression changes in residual advanced cervical cancer after radiotherapy: indicators of poor prognosis and radioresistance?
Fu ZC; Wang FM; Cai JM
Med Sci Monit; 2015 May; 21():1276-87. PubMed ID: 25940978
[TBL] [Abstract][Full Text] [Related]
18. A two‑circRNA signature predicts tumour recurrence in clinical non‑functioning pituitary adenoma.
Guo J; Wang Z; Miao Y; Shen Y; Li M; Gong L; Wang H; He Y; Gao H; Liu Q; Li C; Zhang Y
Oncol Rep; 2019 Jan; 41(1):113-124. PubMed ID: 30542712
[TBL] [Abstract][Full Text] [Related]
19. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
20. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
